ImmPrev Bio

ImmPrev Bio is dedicated to developing and commercializing a new approach for treating Crohn's disease (an inflammatory bowel disease). This approach is based on the research of Dr. Charles Elson, Professor of Gastroenterology and holder of the Chair in Medicine, Microbiology, and Surgery at the University of Alabama at Birmingham.